Assessing olaparib efficacy in U.S. Veterans with metastatic prostate cancer utilizing a time-indifferent -rate method ideal for real-world analyses

Leuva, H., Zhou, M., Jamaleddine, N., Meseha, M., Faiena, I., Anna Park, Y.-H., McWilliams, G., Luhrs, C., Maxwell, K. N., Von Hoff, D., Bates, S. E., & Fojo, T. (2024). Assessing olaparib efficacy in U.S. Veterans with metastatic prostate cancer utilizing a time-indifferent -rate method ideal for real-world analyses. EBioMedicine, 107, 105288. https://doi.org/10.1016/j.ebiom.2024.105288
Authors:
Harshraj Leuva
Mengxi Zhou
Nader Jamaleddine
Mina Meseha
Izak Faiena
Yeun‐Hee Anna Park
Glen McWilliams
Carol Luhrs
Kara N. Maxwell
Daniel D. Von Hoff
Susan E. Bates
Tito Fojo
Affiliated Authors:
Mengxi Zhou
Izak Faiena
Susan E. Bates
Tito Fojo
Columbia Affiliation:
Subjects:
Poly(ADP-ribose) Polymerase Inhibition in Cancer Therapy (OpenAlex Topic)
Advancements in Prostate Cancer Research (OpenAlex Topic)
Statistical Methods in Clinical Trials and Drug Development (OpenAlex Topic)
Author Keywords:
homologous recombination repair
olaparib
real-world data
g-rate
efficacy evaluation
prostate cancer
elink
Publication Type:
Article
Unique ID:
10.1016/j.ebiom.2024.105288
PMID:
39180789
DOI:
10.1016/j.ebiom.2024.105288
Journal:
EBioMedicine
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record
View Web of Science Record

Record Created: